ProPhase Labs, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

Stockholders' Equity (Details Narrative) - USD ($)								3 Months Ended		12 Months Ended
Stockholders' Equity (Details Narrative) - USD ($)	Jan. 21, 2021	Jan. 18, 2021	Jan. 05, 2021	Dec. 12, 2019	Jan. 24, 2019	Sep. 05, 2018	Apr. 12, 2018	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2019	May 05, 2010
Common stock, shares authorized								50,000,000		50,000,000
Common stock, par value								$ 0.0005		$ 0.0005
Preferred stock, shares authorized								1,000,000		1,000,000
Preferred stock, par value								$ 0.0005		$ 0.0005
Preferred stock, shares issued
Proceeds from issuance of common stock and warrants from private offering								$ 5,500,000
Registered Direct Offering [Member]
Number of common stock issued			550,000
Warrants to purchase common stock			275,000
Shares issued price per share			$ 11.00
Proceeds from issuance of common stock and warrants from private offering			$ 5,500
Warrants exercise price			$ 10.00
Public Offering [Member]
Number of common stock issued		3,000,000
Warrants to purchase common stock		180,000
Shares issued price per share		$ 12.50
Proceeds from issuance of common stock and warrants from private offering	$ 35,100
Warrants exercise price		$ 15.625
Description for common stock sold Offering		Common stock (6% of the shares of common stock sold in the Offering) at an exercise price of $15.625 per share (equal to 125% of the public offering price per share).
Common Stock [Member]
Stock option granted									8,346
Director fees									$ 17,000
Warrant [Member]
Share based compensation								$ 147,000
Warrants outstanding shares								905,000
Warrant [Member] \| Registered Direct Offering [Member]
Warrants to purchase common stock									275,000
Warrant [Member] \| Public Offering [Member]
Warrants to purchase common stock									180,000
2010 Directors' Equity Compensation Plan [Member]
Number of shares of common stock issued													675,000
Stock option granted
Stock options, outstanding								200,000
Common stock available for future issuance								128,126
Stock option exercised
2010 Equity Compensation Plan [Member]
Number of shares of common stock issued													3,900,000
Stock options, outstanding								1,295,000
Available for grant, shares								15,659
Share based compensation								$ 779,000
Stock options weighted average period								2 years 9 months 18 days
2010 Equity Compensation Plan [Member] \| Stock Option [Member]
Stock option granted										510,000
2010 Equity Compensation Plan [Member] \| Employees and Non-employees [Member]
Stock option granted								50,000
2018 Stock Incentive Plan [Member]
Common stock available for future issuance							2,300,000
Stock option exercise price per share							$ 3.00
2018 Stock Plan [Member] \| CEO Option [Member]
Stock option exercise price per share				$ 1.50	$ 1.75	$ 2.00
Stock option plan, reduced exercise price per share, description				The exercise price of the CEO Option was further reduced from $1.75 to $1.50 per share, effective as of December 12, 2019,	The exercise price of the CEO Option was further reduced from $2.00 to $1.75 per share.	Exercise price of the CEO Option was reduced from $3.00 per share to $2.00 per share.
2018 Stock Plan [Member] \| Stock Holders [Member] \| CEO Option [Member]
Cash dividend, per shares				$ 0.25	$ 0.25	$ 1.00